Unlisted Deals:
×

New Era Alkaloids and Export Annual Report and Financials

Last Traded Price 10.00 + 0.00 %

New Era Alkaloids and Export Limited (New Era Alkaloids) Return Comparision with Primex 40 Index

Periods 1 Week 1 Month 3 Months 6 Months 1 Year 3 Years All Time
Primex-40
New Era Alkaloids and Export Limited

New Era Alkaloids and Export Limited Balance Sheet (Rs In Lakhs)

Paticulars

2023

2022

ASSETS

 

 

Non- current Assets

 

 

Property ,Plant & equipment

0.06

5.97

Financial Assets

 

 

(i) Investments

1180.17

990.12

(ii) Trade receivables

0

0

(iii) Loans and advances

456.74

793.96

Deferred tax assets (net)

0

0

Other non-current assets

55.27

61.27

Total Non Current Assets

1692.23

1851.31

Current assets

 

 

Financial Assets

 

 

(i) Trade receivables

9.82

1.53

(ii) Cash and cash equivalents

3.39

2.74

(iii) Loans and advances

0

0

Current Tax Assets

0.8

2.85

Other current assets

26.99

29.61

Total Current Assets

41

36.73

Total Assets

1733.23

1888.05

Equity and Liabilities Equity

 

 

Equity Share Capital

328.44

328.44

Other Equity

477.93

387.28

Total Equity

806.37

715.72

Liabilities

 

 

Non Current Liabilities

 

 

Financial Liabilities

 

 

i. Borrowings

 

 

Deferred tax liabilities (net) Other non-current liabilities

493.61

1162.61

 

96.64

1.81

Total Non Current Liabilities

590.25

1164.42

Current Liabilities

 

 

Financial Liabilities

 

 

i. Borrowings

335

0

ii. Tradepayables

 

 

a) Outstanding dues of micro enterprises and small enterprises

0

0

b) Outstanding dues of creditors other than above

0

0.5

iii. Other financial liabilities (other than those specified in item ( 'c)

1.15

6.62

Current Tax Liabilities

0

0

Provisions

0.47

0.79

Total Current Liabilities

336.61

7.91

Total Liabilities

926.86

1172.33

Total Equity and Liabilities

1733.23

1888.05

 New Era Alkaloids and Export Limited Profit & Loss Statement (Rs In Lakhs)

Particulars

31-Mar-23

31-Mar-22

Revenue from operations:

8

6.5

Other income

0.12

22.52

Total Income from Operations

8.12

29.01

EXPENSES

 

 

a. Employees benefits expenses

2.87

8.81

b.  Finance costs

0.01

0.01

c.  Depreciation and amortisation expenses

0.03

0.06

d.  Transportation Expenses

0

0

e. Other Expenses

114.32

9.33

Total expenses (a+b+c+d+e+f+g)

117.23

18.21

Profit/Loss before exceptional items and tax

-109.11

10.8

Profit/Loss before and tax

-109.11

10.8

Tax Expense

0

0

a)  Current Tax

0.01

0.05

b)  Deffered Tax

0

-3.75

c)  Prior Period Tax

 

 

Profit/(loss) for the period

-109.12

14.5

Other comprehensive income

 

 

A. (i) Items that will not be reclassified to profit and loss:

294.59

89.88

(ii) Income tax relating to items that will not be reclassified to profit or loss

-94.82

-10.47

Total Comprehensive Income for the period

90.65

93.91

Paid-up Share Capital (par value Rs. 10/- each fully paid up)

328.44

328.44

Earnings per equity share (Par value Rs. 10 each)

 

 

i) Basic Rs.

2.76

0.44

ii) Diluted Rs.

2.76

0.44

 New Era Alkaloids and Export Limited Consolidated Cash Flow Statement (Rs In Lakhs)

Particulars

Year 2022-23

Year 2021-22

A) Cash Flow From Operating Activities :-

 

 

1. Net Profit/(Loss) before Taxes and Exceptional Items

-109.11

10.8

 Adjustments for:-

 

 

Depreciation

0.03

0.06

Interest Charged to P & L A/c

0.01

0.01

Interest received from parties

0

-22.52

Irrecoverable balances written off

110.42

0

2.Operating Profit before Working Capital Changes

1.35

-11.65

 Adjustments for:-

 

 

Decrease/(Increase) in Trade & Other receivables

339.61

583.97

Increase/(Decrease) in Payables

-6.3

-15.78

Cash generated from Operations

334.66

556.54

Direct Taxes Paid

0

-3.75

Net Cash from Operating Activity (A)

334.66

560.29

B) Cash Flow From Investing Activities :-

 

 

Net Cash from Investing Activity (B)

0

0

C) Cash Flow From Financing Activities :-

 

 

Proceeds from Unsecured Loans ( Net)

-334

-585.96

Proceeds from Short Term Borrowings - Temporary Overdraft

0

0

Interest Paid

-0.01

-0.01

Interst received from parties

0

22.52

Net Cash From Financing Activities (C)

-334.01

-563.45

D) Net Increase / (Decrease) in Cash & Cash Equivalents

0.65

-3.17

E) Cash and Cash Equivalent at beginning of the Year

2.74

5.9

F) Cash and Cash Equivalent at end of the Year (D+E)

3.39

2.74

 Certainly, here is a summary of the Cash Flow Statement for the years 2023 and 2022:

2023:

Cash Flow From Operating Activities:

- 2022-23:

  - Net Cash from Operating Activity: Rs 334.66 crore

- 2021-22:

  - Net Cash from Operating Activity: Rs 560.29 crore

 Cash Flow From Investing Activities:

- 2022-23 and 2021-22: No net cash flow from investing activities reported (both years show "0").

 Cash Flow From Financing Activities:

- 2022-23:

  - Net Cash from Financing Activity: Rs -334.01 crore

- 2021-22:

  - Net Cash from Financing Activity: Rs -563.45 crore

 Net Increase/(Decrease) in Cash & Cash Equivalents:

- 2022-23:

  - Net Increase in Cash: Rs 0.65 crore

- 2021-22:

  - Net Decrease in Cash: Rs -3.17 crore

Cash and Cash Equivalents:

- 2022-23:

  - Cash and Cash Equivalent at end of the Year: Rs 3.39 crore

- 2021-22:

  - Cash and Cash Equivalent at end of the Year: Rs 2.74 crore

New Era Alkaloids & Export Annual Report

New Era Alkaloids And Exports Limited Annual Report 2022-2023

Download
Support Megha Support Neha

News Alert